Charles Ban­croft makes quick leap from Bris­tol My­ers ex­ec team to GSK; Medicxi adds two new part­ners to its team

→ Just a few days af­ter Bris­tol My­ers re­port­ed that Charles Ban­croft had “re­tired” from the ex­ec­u­tive team, he’s made a quick ca­reer shift to the board at Glax­o­SmithK­line. GSK re­port­ed to­day that Ban­croft is tak­ing a non-ex­ec­u­tive di­rec­tor post at the gi­ant phar­ma out­fit. He’s slat­ed to chair GSK’s au­dit & risk com­mit­tee. Ban­croft has ex­ten­sive com­mer­cial and strat­e­gy ex­pe­ri­ence in the busi­ness.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.